Story · Medicine & Biotech

Review of the SPAF-II trial

1 outlet · first reported by Cardiology Trials 16h ago

Coverage, in order

  1. 16h ago
    Cardiology Trials obscure review
    Review of the SPAF-II trial

    Lancet 1994; 343:687-691 Background: The first SPAF trial showed significant reduction of stroke and systemic embolism with warfarin or aspirin use compared to placebo in patient with non-rheumatic atrial fibrillation. Nonetheless, the trial had inadequate power to directly compare warfarin to…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.